Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/03/24
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 12/13/18
End: 11/02/22
Due: 11/02/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Trial of AGB101 for Mild Cognitive Impairment | NCT05986721 | AgeneBio | user2@example.com | None | 2024-12-03 | 2028-12-31 | 2029-12-31 | - | - | 2025-07-14 |
| Study of AGB101 in Mild Cognitive Impairment Due to Alzheimer's Disease | NCT03486938 | AgeneBio | user2@example.com | None | 2018-12-13 | 2022-11-02 | 2023-11-02 | - | - | 2025-07-14 |